| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |